Vivos Therapeutics Inc.
Last updated September 27, 2026
Organization details
- Legal name
- Vivos Therapeutics Inc.
- Former names
- Vivos BioTechnologies, Inc.
- Ownership
- Public
- Status
- Active
- SIC code
- 3841 — Surgical & Medical Instruments & Apparatus
- Jurisdiction of incorporation
- Delaware
- Headquarters city
- Littleton
- Headquarters state / province
- Colorado
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- VVOS
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001716166
- EIN
- 81-3224056
Board of directors
-
Anja B. Krammer · DirectorSince 2024
-
Gregg C. Johnson · DirectorSince 2026
-
Leonard J. Sokolow · DirectorSince 2024
-
Mark F. Lindsay · DirectorSince 2024
-
Matthew Thompson · DirectorSince 2024
-
Ralph Elias Green · DirectorSince 2024
-
Ronald Kirk Huntsman · Director · Chief Executive OfficerSince 2023
Chief executives
Ronald Kirk Huntsman
· Chief Executive Officer
Dates unknown
Director election results
Annual meeting of November 4, 2025. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
88.4%
-
89.6%
-
90.9%
-
92.2%
-
93.0%
-
93.6%
Board connections
2 of this board's directors also sit on 4 other boards.
- via Leonard J. Sokolow
- via Leonard J. Sokolow
- via Leonard J. Sokolow
- via Gregg C. Johnson
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $1,813,858
- 2 purchases by 1 insider
- Sold, last 12 months
- $0
- 0 sales by 0 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jul 31, 2026 | Amman Bradford K. Officer (Principal Accounting Officer) | Grant or award | +250,000 | $0.41 | $102,500 |
| Jun 30, 2026 | Ronald Kirk Huntsman Director, Officer (Chief Executive Officer) | Other | +85,910 | $0.58 | $50,000 |
| Mar 31, 2026 | V-Co Investors 3 LLC 10% owner | Open-market purchase | +1,044,777 | $1.34 | $1,400,001 |
| Mar 31, 2026 | V-Co Investors 3 LLC 10% owner | Open-market purchase | +308,848 | $1.34 | $413,856 |
| Jun 20, 2023 | Ronald Kirk Huntsman Director, Officer (Chief Executive Officer) | Open-market purchase | +14,000 | $0.53 | $7,420 |
| Jun 16, 2023 | Ronald Kirk Huntsman Director, Officer (Chief Executive Officer) | Open-market purchase | +10,000 | $0.54 | $5,400 |
| Jun 16, 2023 | Ronald Kirk Huntsman Director, Officer (Chief Executive Officer) | Open-market purchase | +5,000 | $0.53 | $2,650 |
| Jun 15, 2023 | Ronald Kirk Huntsman Director, Officer (Chief Executive Officer) | Open-market purchase | +21 | $0.50 | $11 |
| Jun 14, 2023 | Ronald Kirk Huntsman Director, Officer (Chief Executive Officer) | Open-market purchase | +10,000 | $0.49 | $4,900 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.